Switch to:

Alexion Pharmaceuticals EV-to-EBITDA

: 24.91 (As of Today)
View and export this data going back to 1996. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Alexion Pharmaceuticals's enterprise value is USD 22,425 Mil. Alexion Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was USD 900 Mil. Therefore, Alexion Pharmaceuticals's EV-to-EBITDA for today is 24.91.

NAS:ALXN' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.6   Med: 40.75   Max: 66.5
Current: 24.91

6.6
66.5

During the past 13 years, the highest EV-to-EBITDA of Alexion Pharmaceuticals was 66.50. The lowest was 6.60. And the median was 40.75.

NAS:ALXN's EV-to-EBITDA is ranked higher than
59% of the 267 Companies
in the Biotechnology industry.

( Industry Median: 31.97 vs. NAS:ALXN: 24.91 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2020-08-14), Alexion Pharmaceuticals's stock price is USD 103.37. Alexion Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 was USD 3.74. Therefore, Alexion Pharmaceuticals's PE Ratio for today is 27.64.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Alexion Pharmaceuticals EV-to-EBITDA Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Alexion Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.48 27.49 24.80 31.38 9.06

Alexion Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-EBITDA Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.35 11.03 9.06 7.31 27.05

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Alexion Pharmaceuticals EV-to-EBITDA Distribution

* The bar in red indicates where Alexion Pharmaceuticals's EV-to-EBITDA falls into.



Alexion Pharmaceuticals EV-to-EBITDA Calculation

Alexion Pharmaceuticals's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=22425.060/900.2
=24.91

Alexion Pharmaceuticals's current Enterprise Value is USD 22,425 Mil.
Alexion Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Jun. 2020 was 645.9 (Sep. 2019 ) + 714.3 (Dec. 2019 ) + 778.7 (Mar. 2020 ) + -1238.7 (Jun. 2020 ) = USD 900 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Alexion Pharmaceuticals  (NAS:ALXN) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Alexion Pharmaceuticals's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=103.37/3.74
=27.64

Alexion Pharmaceuticals's share price for today is USD 103.37.
Alexion Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2020 was 2.08 (Sep. 2019 ) + 4 (Dec. 2019 ) + 2.5 (Mar. 2020 ) + -4.84 (Jun. 2020 ) = USD 3.74.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Alexion Pharmaceuticals EV-to-EBITDA Related Terms


Alexion Pharmaceuticals EV-to-EBITDA Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)